PSYCHOLOGY WIZARD
  • Home
  • Unit 1 FOUNDATIONS
    • Biological >
      • Adoption & Twin Studies AO1 AO2 AO3 >
        • Gottesman & Shields AO1 AO3
        • Kety AO1 AO3
      • Aggression AO1 AO2 AO3 >
        • Evolutionary Psychology AO1 AO2 AO3
      • The Brain AO1 AO2 >
        • Drugs & the Brain AO1 AO2 AO3
      • Brendgen AO1 AO3
      • Development (Maturation) AO1 AO2 AO3
      • Freud's Psychodynamic Theory AO1 AO3 >
        • Aggression & Freud AO1 AO2 AO3
        • Development & Freud AO1 AO2 AO3
        • Individual Differences & Freud AO1 AO2 AO3
      • Raine AO1 AO3
      • Biological Key Question AO1 AO2
    • Cognitive >
      • Baddeley AO1 AO3
      • Multi Store Model AO1 AO2 AO3
      • Reconstructive Memory AO1 AO2 AO3
      • Schmolck AO1 AO3
      • Tulving's Long Term Memory AO1 AO2 AO3
      • Working Memory AO1 AO2 AO3
      • Cognitive Key Question AO1 AO2
    • Learning >
      • Bandura AO1 >
        • Bandura AO3
      • Becker AO1 AO3
      • Classical Conditioning AO1 AO2 AO3
      • Operant Conditioning AO1 AO2 AO3
      • Pavlov AO1 AO3
      • Social Learning AO1 AO2 AO3
      • Therapies for Phobias >
        • Flooding
        • Systematic Desensitisation
      • Watson & Rayner AO1 AO3
      • Learning Key Question AO1 AO2
    • Social >
      • Agency Theory AO1 AO2 AO3
      • Burger AO1 AO3
      • Situational Factors AO1 AO2 AO3
      • Milgram AO1 >
        • Milgram AO3
      • Realistic Conflict Theory AO1 AO2 AO3
      • Sherif AO1 >
        • Sherif AO3
      • Social Impact Theory AO1 AO2 AO3
      • Social Identity Theory AO1 AO2 AO3
      • Social Key Question AO1 AO2
  • Unit 2 APPLICATIONS
    • Clinical >
      • Depression AO1 AO2 >
        • Biological Explanation AO1 AO2
        • Non-Biological Explanation AO1 AO2
        • Biological Treatment AO1 AO2
        • Psychological Treatment AO1 AO2
      • Diagnosing Abnormality AO1 AO2 AO3
      • Diagnostic Manuals AO1 AO2 AO3
      • Carlsson AO1 AO3
      • Kroenke AO1 AO3
      • HCPC Guidelines AO1 AO2 AO3
      • Rosenhan AO1 AO3
      • Schizophrenia AO1 AO2 >
        • Biological Explanation AO1 AO2
        • Non-biological Explanation AO1 AO2
        • Biological Treatments AO1 AO2
        • Psychological Treatment AO1 AO2
      • Clinical Key Question AO1 AO2
      • Issues & Debates >
        • Social Control AO2 AO3
  • Evaluation
    • Ethics AO1 AO2 AO3
    • Individual Differences AO1 AO2 AO3 >
      • Brain Differences AO1 AO2 AO3 >
        • Personality AO1 AO2 AO3
      • Mental Health Differences AO1 AO2 AO3
      • Differences in Obedience & Prejudice AO1 AO2 AO3
      • Memory Differences AO1 AO2 AO3 >
        • Loftus study AO1 AO2 AO3
    • Nature vs Nurture AO1 AO2 AO3
    • Scientific Status AO1 AO2
  • Methods
    • Animal Studies AO1 AO2 AO3
    • Case Studies AO1 AO2 AO3 >
      • Bradshaw AO1 AO3
      • Scoville & Milner AO1 AO3
    • Content Analyses AO1 AO2 AO3
    • Experimental Method AO1 AO2 AO3
    • Experimental Variables AO1 AO2
    • Hypotheses AO1 AO2
    • Inferential Statistics AO1 AO2 >
      • Chi-Squared Test AO1 AO2
      • Mann-Whitney U Test AO1 AO2
      • Spearman's Rho AO1 AO2
      • Wilcoxon Test AO1 AO2
    • Longitudinal Design AO1 AO2 AO3
    • Quantitative Data & Analysis AO1 AO2 AO3
    • Research Design AO1 AO2 AO3
    • Sampling AO1 AO2 AO3
    • Self Report Method AO1 AO2 AO3 >
      • Brown et al. AO1 AO3
  • Blog
  • Contact
  • Resources

BIOLOGICAL TREATMENTS FOR SCHIZOPHRENIA
(ANTIPSYCHOTIC DRUGS)

Picture

BIOLOGICAL TREATMENTS FOR SCHIZOPHRENIA

The Edexcel course requires you to know about one biologically-based treatment for schizophrenia. You will need to be able to compare this with a psychological treatment.
  • The biological treatment is drug therapy (sometimes called pharmacotherapy or chemotherapy)
  • The psychological treatment is cognitive behavioural therapy (CBT)
There are other biological treatments besides drug therapy. For example, there is shock therapy (electro-convulsive therapy or ECT) and psychosurgery (like the frontal lobotomy procedure) but these are uncommon (and unethical) in 21st century medicine.
Picture

DRUG THERAPY SCHIZOPHRENIA
PRESCRIBING ANTIPSYCHOTIC DRUGS

Up until the 1950s, treatment for schizophrenia involved keeping patients sedated and, for more severe cases, the use of shock therapy or crude brain surgery. Then, in 1951, chloropromazine (CPZ) was developed - the world's first antipsychotic drug.

CPZ had been invented in France as an anaesthetic for use on soldiers, but it was noticed it also made people feel better emotionally and had beneficial effects on soldiers traumatised by war. When it was tested on patients with schizophrenia, it reduced positive symptoms dramatically.

CPZ belongs to a family of antipsychotic drugs called phenothiazines (PTZ). It was marketed in the US under the brand name "Thorazine".
  • Thorazine was the medication that Carol had been taking in Bradshaw's case study

TYPICAL ANTIPSYCHOTICS

First generation antipsychotics like PTZ are known as "typical" antipsychotics. They are also called neuroleptics. These drugs block dopamine activity within 48 hours and this seems to be why they are therapeutic for people with schizophrenia. However, it can take several weeks before there is any significant reduction in symptoms.

Although being able to treat schizophrenia with a pill brought about a huge change in mental health care, there were problems with the typical antipsychotics. They had unpleasant symptoms:
  • dryness of mouth
  • blurred vision & grogginess
  • weight gain
  • sleep problems (either insomnia or somnolence - excessive sleeping)
Because these side-effects are unpleasant, it's difficult to keep patients on their medication once they are released from hospital.

The more serious side-effects are even nastier:
  • muscle tremors and spasms
  • drooling

Patients on PTZ often developed a distinctive stumbling walk which was called "the Thorazine shuffle".

The worst side-effect is tardive dyskinesia (TD), which causes uncontrollable facial grimaces and tics. TD affects 25% of all patients who take PTZ for more than 7 years. TD is often irreversible even if the patient stops taking the drugs.
Picture

ATYPICAL ANTIPSYCHOTICS

The first second-generation, or atypical antipsychotic (AAP) drug was clozapine, which appeared in 1971. Risperidone followed in 1993 and olanzapine in the 2000s.

AAPs do not necessarily work by blocking dopamine receptors - clozapine blocks serotonin instead. This means that scientists are not entirely sure why they have the therapeutic effects that they do. They are more powerful than typical antipsychotics and are usually prescribed as a "last resort" or for people for whom the side-effects of PTZ are too severe.

AAPs benefit 85% of patients with schizophrenia, compared with 65% given PTZ (Awad & Voruganti, 1999). Meltzer (1999) found that a third of patients who had shown no improvement with PTZ responded well to clozapine. Moreover, AAPs do treat the negative symptoms as well as positive symptoms (Remington & Kapur, 2000).

It was hoped that AAPs would not have the same side-effects as PTZ. The second generation drugs seemed to have fewer side effects like dry mouth, constipation and TD. In fact, AAPs produce their own side-effects, like diabetes. TD is a possible side-effect with AAPs as well, but onset takes longer (decades). AAps also seem to produce withdrawal effects which increase the symptoms of schizophrenia, so it's important to come off such medication slowly.
Picture
Adverse reactions (side-effects) to all types of antipsychotic: "malaise" is general discomfort; "pancreatitis" is inflammation of the pancreas; TD would fall under "tremor"
Read "Antipsychotics made me want to kill myself"
Picture

APPLYING DRUG THERAPY TO REAL LIFE
WHICH DRUG TO PRESCRIBE?

Which antipsychotic should be prescribed is based on the client's medical history and the previous medication they have tried.

The National Institute for Health and Care Excellence (NICE, 2014) guidance says doctors should discuss the the benefits and side effects of each antipsychotioc with the patient and (ideally) their family members.

People react differently to medication. If one drug doesn’t work well, or causes too many side effects, a doctor will probably change the prescription and try another drug. 

If one antipsychotic has no effect at all, NICE recommends a different antipsychotic be tried after 4-6 weeks. If that does not work, doctors can prescribe AAPs: clozapine is specifically used for people who have not responded to other drugs.

People used to be prescribed several antipsychotics at once. Today's advice is not to offer people more than one antipsychotic drug at a time. The exception to this is when people are prescribed clozapine: if they do not respond to this, NICE says a second antipsychotic may be prescribed at the same time.

THE COURSE OF TREATMENT

It may take a few days, or even a few weeks, before antipsychotics take effect. People with schizophrenia often take antipsychotics for years, even though their symptoms have gone, to stop them becoming unwell again. If they stop taking the drugs too soon, the symptoms may return.

At least half the people diagnosed with schizophrenia don’t take their drugs as recommended. Many people don’t like the idea of taking drugs every day, or forget to take them, or decide they don’t need the drugs any more because they feel well.

People also stop taking their antipsychotic medication because of the side effects. In one survey, some people said they stopped taking medication because they missed hearing voices.

Antipsychotic medication doesn't work for everyone. Researchers estimate that up to 25% of people who are prescribed antipsychotics do not get better. These people are 'treatment-resistant'.

Picture

EVALUATING DRUG THERAPY
AO3

Credibility

Drug therapy represented a major advanced when it was introduced in the 1950s. Antipsychotics are more effective and more ethical than the brain surgery and shock therapy that had been in use before.
Some critics argue that antipsychotics are a "placebo" - they only work because the patient believes they will work. This was tested by Meltzer et al. (2014) who used 481 patients with schizophrenia. The patients were put in 3 conditions: (1) patients receiving one of four new trial drugs; (2) patients receiving a typical antipsychotic (haloperidol); (3) patients receiving a placebo (a pill that looked like an antipsychotic but had no effect).
Picture
After 6 weeks, patients taking haloperidol and two of the trial drugs had reduced symptoms. Patients taking the placebo and two of the other trial drugs were still the same. This shows that antipsychotics do better than placebos and really do reduce symptoms.

Drug therapy is supported by the Dopamine Hypothesis and lends support to the biological explanation of schizophrenia. All antipsychotics affect neurotransmitters in the brain to bring about changes in symptoms. When an idea is backed up by a well-researched scientific theory, it has construct validity.
Objections

Drug therapy doesn't work for everyone. Although more patients respond to the atypical drugs than to the first generation antipsychotics, this is still not all patients. It is estimated 50-65% of patients benefit from drug treatments.

The main weakness of drug therapy is that it isn’t a cure, it just temporarily reduces the symptoms; as soon as the patient stops taking them, the symptoms return, usually within 3-6 weeks. The first generation antipsychotics were criticised for being a "chemical straitjacket" that turned patients into shuffling, drooling zombies. There are issues of social control here: drugs might be prescribed, not because they help the patient, but because they make the patient easier for hospital staff to control.
The classic film One Flew Over The Cuckoo's Nest (1975) shows how the hospital staff hand out medication to control the patients and keep them docile and obedient
All the drugs used to treat schizophrenia have adverse reactions; these could include weight gain, tremors and drowsiness. Some people feel the side-effects are worse than the symptoms they are alleviating. The Recovery Model takes a different approach, urging people with schizophrenia to stop taking drugs and find different ways of living with their symptoms. Harlow et al. (2012) carried out a 20-year longitudinal study and found that patients who did not take their medication had fewer psychotic episodes than those who did. 
Summary of the Harlow study
The Recovery Movement makes some good points but also advocates a lot of conspiracy theories, like the idea that the medical drugs companies ("Big Pharma") deliberately push expensive AAPs onto people to boost their own profits.

Nonetheless, there is a growing concern that antipsychotics are being over-prescribed:
For some people, remaining on medication long-term might impede a full return to wellness. For others, discontinuing medication can be disastrous - Thomas Insel
Differences
The alternative treatment we are considering is cognitive behavioural therapy (CBT)
CBT used to be considered inappropriate for schizophrenia because cognitive therapy involves talking and thinking clearly - exactly what schizophrenia interferes with. However, Bradshaw (1998) challenged this with a case study that showed a patient (Carol) benefiting from CBT.

The great advantage of CBT over drug therapy is the lack of side-effects. On the other hand, cognitive therapy can be more threatening for some patients, because you have to open up and talk about your problems. For some people, popping a pill is preferable to sharing unpleasant thoughts and feelings with a therapist.

Both treatments take time to be effective: drug therapy takes days-to-weeks, cognitive therapy takes months. This means a patient who is very distressed and perhaps suicidal will get much more help in the short term from antipsychotics.

However, in the long term, CBT might be more beneficial. Carol showed that the benefits of CBT were still there a year after the therapy ended. Whereas, the longer someone takes antipsychotics, the more likely severe side-effects will develop and, if they stop taking the drugs, their symptoms will return.

CBT seems to be most effective with clients who have good problem solving skills. For this reason it has not been seen as appropriate for psychotic patients (Ellis, 1980). However recent studies (Kingdon and Turkington, 1994) suggest that, in combination with anti-psychotic drugs, CBT can reduce delusions and disturbing hallucinations (through reality testing). An "integrated approach" involves combining the two treatments. It may be possible to reduce the dependency on antipsychotics as the cognitive therapy takes effect.
Applications

Research has proven these drugs work. Antipsychotics have long been established as a relatively cheap, effective treatment, which quickly reduce symptoms and enable many people to live relatively normal lives (Van Putten, 1981). Relapse is likely when patients stop taking the drugs. Drug treatment is usually superior to no treatment at all. Between 50–65% of patients benefit from drug treatments.

One of the big positives of drug therapy is that it requires very little effort from the client; they just have to take some pills. However, this is not always true as most doctors use drug therapy alongside another treatment, like counseling or family therapy. This is an "integrated approach".

However, there's a risk that patients stop taking their medication. They may do this because they don't understand their illness, because their relationship with their clinician isn't very good or because they don't like the side-effects. Rosenhan (1973) instructed his pseudopatients to flush their medication down the toilet and they discovered that the other genuine patients were doing the same.
Being medicated involves the admission of needing someone else’s help…It is an admission of some degree of helplessness - Jack Bergen
James Stone (2012) refers to the "new dawn" of antipsychotic medication: drugs that target glutamate rather than dopamine. These drugs are still in clinical trials but they promise to reduce positive and negative symptoms without the harmful side-effects of drugs that target dopamine. The theory behind this is reviewed in the contemporary study into schizophrenia by Carlsson et al. (1999).
Picture

EXEMPLAR ESSAY
How to write a 8-mark answer

Using your knowledge of schizophrenia, assess how effective a biological treatment would be
compared to a psychological treatment. (8 marks)
  • A 8-mark “evaluate” question awards 4 marks for describing biological treatments (AO1) and 4 marks for evaluating them, including a comparison (AO2). You need a conclusion to get a mark in the top band (7-8 marks).

Description
Drug treatment for schizophrenia involves prescribing antipsychotics which alter brain chemistry to reduce the symptoms.
First generation "typical" antipsychotics appeared in the 1950s. The most common a phenothiazines (PTZ) which block dopamine receptors.
Second generation "atypical" antipsychotics appeared in the 1990s, although the first was clozapine in the '70s. Clozapine reduces serotonin activity instead.
Antipsychotics take days or weeks to have an effect. If a patient doesn't respond to typical antipsychotics they may be prescribed clozapine instead.

Evaluation
Drug treatment has been described as a "chemical straitjacket" because it only tackles the symptoms, not the cause.
The side-effects of antipsychotics can be severe and permanent, such as disfiguring facial tics.
For this reason, many patients stop taking their medication. Studies like Harlow et al. suggest that patients who come off their medication actual recover better than those who stay on it.
In contrast, cognitive therapies tackle the underlying causes and produce longlasting benefits without side-effects. In Bradshaw's case study, Carol reduced her symptoms for a year after finishing a course of CBT.

Conclusion
There are short-term benefits from drug therapy, especially for dangerous or suicidal patients, but in the long run an integrated approach of CBT and antipsychotics will work best.

  • Notice that for a 8-mark answer you don’t have to include everything about tdrug therapy. You will notice I haven't mentioned the Thorazine shuffle, Big Pharma or placebos. But it is a balanced answer - one half description and one half evaluation.
Home
Blog
Contact

PSYCHOLOGYWIZARD.NET
  • Home
  • Unit 1 FOUNDATIONS
    • Biological >
      • Adoption & Twin Studies AO1 AO2 AO3 >
        • Gottesman & Shields AO1 AO3
        • Kety AO1 AO3
      • Aggression AO1 AO2 AO3 >
        • Evolutionary Psychology AO1 AO2 AO3
      • The Brain AO1 AO2 >
        • Drugs & the Brain AO1 AO2 AO3
      • Brendgen AO1 AO3
      • Development (Maturation) AO1 AO2 AO3
      • Freud's Psychodynamic Theory AO1 AO3 >
        • Aggression & Freud AO1 AO2 AO3
        • Development & Freud AO1 AO2 AO3
        • Individual Differences & Freud AO1 AO2 AO3
      • Raine AO1 AO3
      • Biological Key Question AO1 AO2
    • Cognitive >
      • Baddeley AO1 AO3
      • Multi Store Model AO1 AO2 AO3
      • Reconstructive Memory AO1 AO2 AO3
      • Schmolck AO1 AO3
      • Tulving's Long Term Memory AO1 AO2 AO3
      • Working Memory AO1 AO2 AO3
      • Cognitive Key Question AO1 AO2
    • Learning >
      • Bandura AO1 >
        • Bandura AO3
      • Becker AO1 AO3
      • Classical Conditioning AO1 AO2 AO3
      • Operant Conditioning AO1 AO2 AO3
      • Pavlov AO1 AO3
      • Social Learning AO1 AO2 AO3
      • Therapies for Phobias >
        • Flooding
        • Systematic Desensitisation
      • Watson & Rayner AO1 AO3
      • Learning Key Question AO1 AO2
    • Social >
      • Agency Theory AO1 AO2 AO3
      • Burger AO1 AO3
      • Situational Factors AO1 AO2 AO3
      • Milgram AO1 >
        • Milgram AO3
      • Realistic Conflict Theory AO1 AO2 AO3
      • Sherif AO1 >
        • Sherif AO3
      • Social Impact Theory AO1 AO2 AO3
      • Social Identity Theory AO1 AO2 AO3
      • Social Key Question AO1 AO2
  • Unit 2 APPLICATIONS
    • Clinical >
      • Depression AO1 AO2 >
        • Biological Explanation AO1 AO2
        • Non-Biological Explanation AO1 AO2
        • Biological Treatment AO1 AO2
        • Psychological Treatment AO1 AO2
      • Diagnosing Abnormality AO1 AO2 AO3
      • Diagnostic Manuals AO1 AO2 AO3
      • Carlsson AO1 AO3
      • Kroenke AO1 AO3
      • HCPC Guidelines AO1 AO2 AO3
      • Rosenhan AO1 AO3
      • Schizophrenia AO1 AO2 >
        • Biological Explanation AO1 AO2
        • Non-biological Explanation AO1 AO2
        • Biological Treatments AO1 AO2
        • Psychological Treatment AO1 AO2
      • Clinical Key Question AO1 AO2
      • Issues & Debates >
        • Social Control AO2 AO3
  • Evaluation
    • Ethics AO1 AO2 AO3
    • Individual Differences AO1 AO2 AO3 >
      • Brain Differences AO1 AO2 AO3 >
        • Personality AO1 AO2 AO3
      • Mental Health Differences AO1 AO2 AO3
      • Differences in Obedience & Prejudice AO1 AO2 AO3
      • Memory Differences AO1 AO2 AO3 >
        • Loftus study AO1 AO2 AO3
    • Nature vs Nurture AO1 AO2 AO3
    • Scientific Status AO1 AO2
  • Methods
    • Animal Studies AO1 AO2 AO3
    • Case Studies AO1 AO2 AO3 >
      • Bradshaw AO1 AO3
      • Scoville & Milner AO1 AO3
    • Content Analyses AO1 AO2 AO3
    • Experimental Method AO1 AO2 AO3
    • Experimental Variables AO1 AO2
    • Hypotheses AO1 AO2
    • Inferential Statistics AO1 AO2 >
      • Chi-Squared Test AO1 AO2
      • Mann-Whitney U Test AO1 AO2
      • Spearman's Rho AO1 AO2
      • Wilcoxon Test AO1 AO2
    • Longitudinal Design AO1 AO2 AO3
    • Quantitative Data & Analysis AO1 AO2 AO3
    • Research Design AO1 AO2 AO3
    • Sampling AO1 AO2 AO3
    • Self Report Method AO1 AO2 AO3 >
      • Brown et al. AO1 AO3
  • Blog
  • Contact
  • Resources